Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), will release one-year data from the ORBIT II study of the company’s Diamondback 360® Coronary Orbital Atherectomy System in treating severely calcified lesions. The data will be presented as an iMPACT Trial at the 2014 Cardiovascular Research Technologies (CRT) conference in Washington, D.C., Feb. 22-25, 2014. CRT’s iMPACT Trials are innovative reports that provide the latest breakthroughs in clinical science.
Help employers find you! Check out all the jobs and post your resume.
